Steve Sloan’s last official function as GALVmed CEO was on 1 December 2011 when he attended the commissioning event for the equipment and facilities provided to the National Veterinary Institute, Ethiopia under the VACNADA programme.
The process for recruiting Steve’s successor is currently underway. Meanwhile an Interim CEO has been appointed – Professor Peter Wells. Peter is already well known to many of the GALVmed team, having served on two advisory committees and attended board meetings as an observer. Peter has close to 30 years experience of the veterinary pharmaceutical industry and has served in senior positions with a number of leading companies in the UK. He also has research experience in veterinary microbiology and vaccinology in Europe, North America and Africa, and has a PhD in veterinary pharmacology.
Peter Wells commented:
Steve Sloan has invested an incredible amount of energy and commitment in GALVmed, from its inception, through infancy, to the maturing organisation that I have experienced it to be over the past two years as a member of both GALVmed’s Expert Scientific Committee and the Tryps Programme Steering Committee. I know GALVmed to be focused on delivery for resource-poor livestock keepers by working entirely through partnerships. This alliance has broadly-based expertise and strong leadership from the developing world in the board, directorate and partners. I look forward to supporting Chairman Shadrack Moephuli and to being a ‘bridge’ for GALVmed’s staff and stakeholders, going forward.